Wie sind die Öffnungszeiten?

Montag 09:00 - 18:00 Dienstag 09:00 - 18:00 Mittwoch 09:00 - 18:00 Donnerstag 09:00 - 18:00 Freitag 09:00 - 18:00

TVNS Health

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von TVNS Health, Medizin und Gesundheit, Südliche Münchner Str. 62, Grünwald.

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices, the product of tVNS Technologies Gmbh, for the selected regions.

09/10/2025

Living with the lingering effects of post-COVID can feel overwhelming, but there are new approaches designed to help.

The tVNS® E device offers a non-invasive, medication-free, and low side-effect option that is medically certified under EU MDR. By stimulating the vagus nerve gently through the ear, tVNS® supports the body's natural regulatory systems, with applications being explored for both neurological conditions and post-COVID recovery.

Our expert team is here to guide you through every step, answering your questions, explaining clinical evidence, and helping you understand whether tVNS® could be right for your situation.

Learn more and connect with us today at www.tvns.health

06/10/2025

Anxiety and depression remain some of the most common challenges in modern healthcare—often requiring long-term treatment options.

The tVNS® device offers a non-invasive, drug-free alternative. By gently stimulating the vagus nerve, it has shown effectiveness in reducing symptoms of anxiety and depression. Research highlights that activating this pathway helps the brain process stress more calmly, providing a more accessible route toward emotional balance.

For many, tVNS® represents a valuable complement to existing therapies, opening doors to a safer and more sustainable approach in mental health care.

Learn more about the tVNS® at www.tvns.health.

04/10/2025

A Certified Medical Device for Daily Neuromodulation

tVNS® E is a CE-certified Class IIa medical device approved under EU‑MDR for non-invasive vagus nerve stimulation via the ear. Designed for safe use at home or in clinical settings, it is approved for both adults and children aged 3 and older.

Validated in peer-reviewed studies and used across a range of conditions — from tinnitus and depression to chronic fatigue and long COVID — tVNS® offers a structured, scientifically grounded approach to neuromodulation.

✅ Certified Non-Invasive Transcutaneous Vagus Nerve Stimulation Device
✅ Non-Invasive & Medication-Free
✅ Clinically Proven and Trusted by Institutions Across the World

Learn more about the clinical evidence, safety data, and protocols at www.tvns.health

03/10/2025

tVNS Health GmbH acts as the distribution and service gateway for the pioneering tVNS® auricular vagus nerve stimulation device, developed by tVNS Technologies GmbH in Germany.

Our responsibility is to:

• Deliver this breakthrough neuromodulation therapy to selected countries in Europe and all regions in Asia, Africa, Oceania, and South America.

• Ensure that clinicians, patients, and partners receive reliable service, training, and support.

• Facilitate the global accessibility of non-invasive vagus nerve stimulation backed by clinical research.

Through this role, tVNS Health GmbH connects innovation with healthcare systems worldwide, bringing safe and effective neuromodulation solutions closer to those who need them.

21/09/2025

💜 World Alzheimer's Day – September 21

Alzheimer's disease deeply impacts not only individuals but also families and communities worldwide.
Clinical studies show that tVNS® stimulates brain networks involved in memory and learning, supporting cognitive health.

🔹 Supports and strengthens memory
🔹 Enhances brain connectivity
🔹 Promotes overall cognitive health

Learn more: www.tvns.health

10/09/2025

Today, we raise awareness for su***de prevention and stand together to remind one another that there is always hope.

Suicidal thoughts and depression affect millions worldwide, with adolescence being a particularly vulnerable period. Unfortunately, many young people do not respond to conventional treatments, leaving families and clinicians searching for new, safe, and effective approaches.

A recent case report published in The Journal of Pediatrics (2024) described a young patient with treatment-resistant depression and suicidal thoughts who received tVNS® (transcutaneous auricular vagus nerve stimulation) over several months. The treatment was applied safely in a home setting, with no serious side effects, and the patient was able to regain stability, complete her high school graduation, and start a new chapter in her life.

This case illustrates the promise of tVNS® as a supportive therapy for patients who have not found relief through traditional methods. While more studies are needed, such evidence brings hope to patients, families, and healthcare professionals worldwide.

On this important day, let's remember: mental health matters, treatment options are evolving, and hope is always possible.

05/09/2025

tVNS® in Osteoarthritis Research: A New Direction for Pain Modulation
A 2025 pilot trial, published in Osteoarthritis and Cartilage Open, investigated the safety and preliminary effects of auricular tVNS® for individuals living with chronic knee osteoarthritis.

Thirty participants received a single 60-minute session of ear-based vagus nerve stimulation. The results:
• The treatment was well tolerated
• No adverse events were reported
• Early data showed a clinically meaningful reduction in knee pain scores

Unlike conventional joint-targeted treatments, this approach modulates central pain processing via the vagus nerve — targeting the brain, not the joint.

The findings suggest that tVNS® may offer a safe, non-invasive option for patients with chronic pain, with larger clinical trials already underway.

Explore more at www.tvns.health

27/08/2025

Depression doesn't just affect mood—it affects motivation.
Many patients report struggling to start tasks, chase goals, or feel rewarded by progress. That's where tVNS® may offer support.

A 2024 clinical study published in Comprehensive Psychiatry found that tVNS® boosted motivation to pursue rewards, not only in healthy individuals but also in patients with major depressive disorder.

Researchers observed:
• Increased drive to initiate and sustain effort
• Greater ease with effort-based learning
• Reduced negative perception of mental exertion

This suggests that tVNS® may help regulate the neural pathways responsible for reward processing and cognitive motivation—critical for anyone facing the weight of depression.

tVNS® is non-invasive, medication-free, and EU-MDR certified, making it accessible for daily use at home.

Discover how neurostimulation may support your recovery at www.tvns.health

12/08/2025

Dr. Issa H. Almashmoom, Specialist in Neurology and Epilepsy, shares his professional insight on how transcutaneous vagus nerve stimulation (tVNS®) is transforming epilepsy care.

This innovative, non-invasive therapy is worn comfortably on the ear and can be used for up to four hours a day. Clinical experience shows it may help reduce seizures, relieve neurological symptoms, and improve overall quality of life,all without pain or side effects.

tVNS® represents a new era in neuromodulation, offering patients and healthcare providers a safe, effective, and surgery-free option in managing neurological disorders.

06/08/2025

After battling post-COVID symptoms that left her unable to move, speak, or carry out even the most basic daily tasks, Johanna K. faced an uncertain and frightening future. With no clear diagnosis and no effective treatment available, she was sent home; weak, voiceless, and dependent on others for care.

In mid-2023, as part of her recovery journey, Johanna began using our tVNS® device under clinical supervision. This non-invasive therapy gently stimulates the vagus nerve through the outer ear, supporting the autonomic nervous system and neuroimmune balance, both of which are often disrupted in long COVID.

Over time, Johanna began to notice early signs of progress. She started regaining physical strength, emotional stability, and most importantly, a sense of control over her own life.

While many factors may have contributed to her improvement, her experience highlights the potential role of neuromodulation in complex recovery journeys, especially where conventional medicine has little to offer.

Today, Johanna's story serves as a reminder:

Recovery is possible. And sometimes, it begins with a spark of stimulation.

05/08/2025

The NHS-backed TRICEPS trial is investigating how tVNS®, non-invasive vagus nerve stimulation device, can enhance stroke rehabilitation.

By pairing stimulation with arm movement, this innovative approach aims to restore hand function in patients even years after a stroke.

A promising step toward global adoption of tVNS® therapy.

A major UK-wide clinical trial is now exploring how our tVNS® device could transform upper limb rehabilitation after stroke.

Led by researchers in Sheffield and supported by NHS centres including Bournemouth, Sherborne, and Dorchester, the TRICEPS trial uses our non-invasive ear-clip device to gently stimulate the vagus nerve during movement therapy, helping strengthen hand and arm function.

One participant, Ian Odd, said:

“Even four years after my stroke, I wasn't improving… but this trial gives people hope.”

No surgery. Home-friendly use. Scientifically backed.

A new chapter in post-stroke rehabilitation may be on the horizon.

04/08/2025

tVNS® in Media

ARD – W wie Wissen recently featured a report on the use of our tVNS® device in the treatment of obesity, in a clinical study led by Prof. Dr. Nils Kroemer at the University of Bonn.

“The vagus nerve is the body's secret communication highway,” says Prof. Kroemer.
“It transmits signals from the organs to the brain, shaping how full we feel and influencing motivation, factors that are essential in obesity treatment.”

In this televised segment, Prof. Kroemer's team is using the tVNS® device developed in Germany, which stimulates the auricular branch of the vagus nerve via the outer ear, non-invasively, without surgery or medication.

The study explores how vagus nerve stimulation may support behavioral change and appetite regulation by modulating activity in brain regions related to self-control and reward processing.

We are proud that the tVNS® system used in this research is part of our mission to advance safe and effective neuromodulation technologies for a range of clinical applications.

Watch the full episode on ARD Mediathek:
https://www.ardmediathek.de/video/w-wie-wissen/vagusnerv-stimulation-gegen-adipositas/das-erste/Y3JpZDovL2Rhc2Vyc3RlLmRlL3cgd2llIHdpc3Nlbi9kYjE4NGIwOS03MmRmLTQ3MTktYWU1MS1kNDYzYTI4MjUwZGY

Contact us and learn more about tVNS® at tvns.health

Adresse

Südliche Münchner Str. 62
Grünwald
82031

Öffnungszeiten

Montag	09:00 - 18:00
Dienstag	09:00 - 18:00
Mittwoch	09:00 - 18:00
Donnerstag	09:00 - 18:00
Freitag	09:00 - 18:00

Webseite

https://tvns.health/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TVNS Health erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.